Brief: Alkermes Receives Interim Award In Arbitration Proceedings With Janssen Pharmaceutica
06/01/2023 13:44
Jan 6 (Reuters) - Alkermes Plc ALKS.O :
* ALKERMES PLC - ON DEC 21, 2022 RECEIVED INTERIM AWARD IN
ARBITRATION PROCEEDINGS WITH JANSSEN PHARMACEUTICA N.V., UNIT OF
JOHNSON & JOHNSON
* ALKERMES PLC - ALKERMES WILL ENGAGE WITH JANSSEN AND THE
TRIBUNAL IN ADDITIONAL PROCEEDINGS PRIOR TO THE TRIBUNAL’S
ISSUANCE OF A FINAL AWARD
* ALKERMES PLC - INTERIM AWARD IN RESPECT OF JANSSEN'S
PARTIAL
TERMINATION IN UNITED STATES OF TWO LICENSE AGREEMENTS WITH
COMPANY
Further company coverage: ALKS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alkermes
See all newsBrief: Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study Of Alixorexton In Adults With Narcolepsy Type 2 At Sleep 2026
Brief: Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating Lumryz
Brief: Alkermes Announces Effectiveness Of Mural Oncology Form 10 Registration Statement
Alkermes Plc reports results for the quarter ended in September - Earnings Summary
Brief: Alkermes Q3 Net Income USD 47.8 Million